Rad Tech CE, ASRT, ARRT® CE, Category A Credits | Radiology Continuing Education

Approvals/Requirements Satisfied by eRADIMAGING Courses

  • ASRT approval for ARRT Category A credit
  • All Courses eligible of international radiographers' CPD requirements
  • ASRT and MDCB are approved continuing education providers of ARRT and all courses are accepted by ARRT
  • California CE requirements met for all radiography courses
  • NMTCB accepted (All Courses)
  • All Courses available for RRAs
  • ARMRIT accepted (All MRI Courses)
  • MDCB approval by the Medical Dosimetrist Certification (Selected Courses)
  • Florida approval for all courses 1 credit or more
  • ARDMS accepted (All Courses)
  • CAMRT and Sonography Canada recognize the ASRT approval (All Courses)
  • Approval: This course is approved by ASRT - an approved continuing education provider of ARRT.
  • Release Date: 3/6/2020
  • Expiration Date: 4/1/2023
  • Credit Hours: 1 Credit
  • Course Description and objectives:


    Course Description
    Follicular lymphoma (FL) is usually a slow-growing or indolent form of non-Hodgkin’s lymphoma. It arises from B-lymphocytes and accounts for 20 to 30 percent of all cases of non-Hodgkin’s lymphoma. Enlargement of the lymph nodes in the neck, underarms, abdomen, or groin, as well as fatigue, shortness of breath, night sweats, and weight loss are common symptoms. Often, patients with FL have no obvious symptoms of the disease at diagnosis. FL is not considered curable, but more of a chronic disease that patients can live with for many years.

    Most types of lymphoma are metabolically active and use more glucose compared with normal structures. Position emission tomography/computed tomography using 18F-fluordeoxyglucose (18F-FDG PET/CT), has demonstrated an important role for staging, monitoring for recurrence, restaging, and prognostication in patients at critical points in their treatment of FL to optimize their health and longevity. FL is FDG-avid in more than 95% of the cases. Despite this high affinity, 18F-FDG PET/CT use for baseline staging in clinical practice became standard only in 2014. Since that time, the role of 18F-FDG PET/CT has expanded to all aspects of management of patients with FL.

    Learning Objectives
    After reading this article, the participant should be able to:

    • Describe the epidemiology of follicular lymphoma.
    • Explain important imaging parameters for follicular lymphoma assessment.
    • Define prognostic impact of 18F-FDG PET/CT after first-line treatment in follicular lymphoma.
    • Identify key parameters impacting 18F-FDG PET/CT scans in follicular lymphoma.

    Categories: Nuclear Medicine, Computed Tomography

  • CE Information:

    CE Information
    In order to receive CE credit, you must first complete the activity content. When completed, go to the “Take CE Test!” link to access the post-test.

    Submit the completed answers to determine if you have passed the post-test assessment. You must answer 6 out of 8 questions correctly to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test.

    Participants successfully completing the activity content and passing the post-test will receive 1.0 ARRT Category A credits.

    Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

    Approved by the state of Florida for ARRT Category A credit.

    Texas direct credit.

    This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

     


PET and PET/CT in the Diagnosis and Management of Follicular Lymphoma

Linda Giering, PhD*

*Medical Writer, Matawan, New Jersey

Address correspondence to: Linda Giering, PhD. Email: lindagiering@gmail.com.

Disclosure statement: The author reports having no significant financial or advisory relationships with corporate organizations related to this activity.

 

ABSTRACT

Follicular lymphoma (FL) is usually a slow-growing or indolent form of non-Hodgkin's lymphoma. It arises from B-lymphocytes and accounts for 20 to 30 percent of all cases of non-Hodgkin's lymphoma. Enlargement of the lymph nodes in the neck, underarms, abdomen, or groin, as well as fatigue, shortness of breath, night sweats, and weight loss are common symptoms. Often, patients with FL have no obvious symptoms of the disease at diagnosis. FL is not considered curable, but more of a chronic disease that patients can live with for many years.

Most types of lymphoma are metabolically active and use more glucose compared with normal structures. Position emission tomography/computed tomography using 18F-fluordeoxyglucose (18F-FDG PET/CT), has demonstrated an important role for staging, monitoring for recurrence, restaging, and prognostication in patients at critical points in their treatment of FL to optimize their health and longevity. FL is FDG-avid in more than 95% of the cases. Despite this high affinity, 18F-FDG PET/CT use for baseline staging in clinical practice became standard only in 2014. Since that time, the role of 18F-FDG PET/CT has expanded to all aspects of management of patients with FL.     

View the full content

Sample eRADIMAGING Course *

* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.

Become a member

Satisfy your CE requirements today!

Join now

We offer special group rates, call or email.

908-253-9001

webmaster@eradimaging.com

Newsletter

Enter your email address to receive our new course alerts.